Cargando…
Micronized Palmitoylethanolamide-Polydatin Reduces the Painful Symptomatology in Patients with Interstitial Cystitis/Bladder Pain Syndrome
AIMS: To assess the efficacy of a micronized-palmitoylethanolamide-polydatin (m-PEA-Pol) based product on chronic pelvic pain and severity of other symptoms in interstitial cystitis/bladder pain syndrome (IC/BPS) patients refractory to conventional therapies. METHODS: A pilot, open-label bicentric s...
Autores principales: | Cervigni, M., Nasta, L., Schievano, C., Lampropoulou, N., Ostardo, E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885282/ https://www.ncbi.nlm.nih.gov/pubmed/31828153 http://dx.doi.org/10.1155/2019/9828397 |
Ejemplares similares
-
Interstitial cystitis/bladder pain syndrome and glycosaminoglycans replacement therapy
por: Cervigni, Mauro
Publicado: (2015) -
Effect of ultramicronized-palmitoylethanolamide and co-micronized palmitoylethanolamide/polydatin on chronic pelvic pain and quality of life in endometriosis patients: An open-label pilot study
por: Stochino Loi, Emanuela, et al.
Publicado: (2019) -
Looking for Responders among Women with Chronic Pelvic Pain Treated with a Comicronized Formulation of Micronized Palmitoylethanolamide and Polydatin
por: Indraccolo, Ugo, et al.
Publicado: (2022) -
Bladder Pain Syndrome and Interstitial Cystitis Beyond Horizon: Reports from the Global Interstitial Cystitis/Bladder Pain Society (GIBS) Meeting 2019 Mumbai – India
por: Rahnama'i, Mohammad Sajjad, et al.
Publicado: (2020) -
Micronized Palmitoylethanolamide Reduces the Symptoms of Neuropathic Pain in Diabetic Patients
por: Schifilliti, Chiara, et al.
Publicado: (2014)